Indian chemical and pharmaceutical groups are positioning themselves as an alternative to China as the coronavirus crisis prompts companies to diversify their supply chains.
隨著新型冠狀病毒危機促使企業實現供應鏈多元化,印度化工和制藥公司正將自己定位成中國的替代者。
您已閱讀4%(219字),剩余96%(4719字)包含更多重要信息,訂閱以繼續探索完整內容,并享受更多專屬服務。